NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Novo Nordisk securities between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI). Investors who purchased Owens & Minor securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OMI.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Premier, Inc. ("Premier" or "the Company") (NASDAQ:PINC). Investors who purchased Premier securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PINC.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dominion Energy, Inc. ("Dominion" or "the Company") (NYSE:D). Investors who purchased Dominion securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/D.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation ("FMC" or "the Company") (NYSE:FMC). Investors who purchased FMC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FMC.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") (NASDAQ:STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluence Energy, Inc. ("Fluence" or "the Company") (NASDAQ:FLNC). Investors who purchased Fluence securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLNC.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pliant Therapeutics, Inc. ("Pliant" or "the Company") (NASDAQ:PLRX). Investors who purchased Pliant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PLRX.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC ("Barclays" or "the Company") (NYSE:BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BCS.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Trade Desk, Inc. ("Trade Desk" or "the Company") (NASDAQ:TTD). Investors who purchased Trade Desk securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TTD.

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Alarum Technologies Ltd. ("Alarum" or "the Company") (NASDAQ:ALAR) and certain of its officers.

USFD delivers a strong fiscal fourth-quarter performance, driven by growth in total independent case volume.

Despite Moody's latest negative rating, Walgreens' focus on operational turnaround and improving cash flows makes it a good hold.

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

ROST, LDOS, RJF, FTNT and PPC are some of the stocks with high ROE to profit from as fears of inflation and reciprocal tariffs take the backseat.

As Cheniere Energy gears up to report Q4 earnings on Feb. 20,, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Outbrain (OB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Dana (DAN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.